Active Ingredient: Melphalan hydrochloride 50mg
Dosage Form: Powder for solution for injection
Indication: It is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
Packaging: Box of 1 Powder + 10mL vial of sterilised diluent
Manufacturer: GlaxoSmithKline – Italy
MAH: Aspen Pharma Trading Limited – Ireland